News

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.

Dr. Matthew Wilkinson, a transplant surgeon at Saint Luke’s talks about the advances in organ donation and the importance of living organ donation.

FOX4 talked to Dr. Karin Olds about Guillain-Barre Syndrome and recovery.

Melissa Magwire talks about why diabetes is a population health problem and a unique program at Saint Luke's that is helping patients across the nation.

More than 100,000 people are on the wait list for a life-saving transplant—and more than 85% of those can be helped by a living donor.

KCTV talked to Melissa Magwire,RN, MSN, CDE, program director of the Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence, to learn more about the Cardiometabolic Center.

A recent study out of Harvard School of Public Health found a strong relationship between those who had mononucleosis, or the “kissing disease,” and multiple sclerosis later in life.

An expert with Saint Luke’s Comprehensive Multiple Sclerosis Center discusses early detection and exciting new advances in treatment.